{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:49:59Z","timestamp":1790293799326,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81690263"],"award-info":[{"award-number":["81690263"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jconrel.2020.08.030","type":"journal-article","created":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T21:15:14Z","timestamp":1598303714000},"page":"78-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"special_numbering":"C","title":["Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy"],"prefix":"10.1016","volume":"328","author":[{"given":"Songli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunyi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.08.030_bb0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/CIR.0b013e3182456d46","article-title":"Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association","volume":"125","author":"Roger","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.CIR.96.3.761","article-title":"Clearance of tissue plasminogen activator (TPA) and TPA\/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels","volume":"96","author":"Chandler","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0015","first-page":"938","article-title":"Mechanisms of thrombus formation","volume":"359","author":"Furie","year":"2008","journal-title":"Chapter"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0020","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood-2013-03-453498","article-title":"Advanced drug delivery systems for antithrombotic agents","volume":"122","author":"Greineder","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0025","doi-asserted-by":"crossref","first-page":"6194","DOI":"10.1021\/acsnano.7b02308","article-title":"Fibrin-targeted and H2O2-responsive nanoparticles as a theranostics for thrombosed vessels","volume":"11","author":"Kang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0030","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7150\/thno.14514","article-title":"Thrombus-targeted theranostic microbubbles: a new technology towards concurrent rapid ultrasound diagnosis and bleeding-free fibrinolytic treatment of thrombosis","volume":"6","author":"Wang","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0035","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s11095-013-1011-x","article-title":"Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy","volume":"30","author":"Absar","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.08.030_bb0040","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biomaterials.2017.03.012","article-title":"Platelet microparticle-inspired clot-responsive nanomedicine for targeted fibrinolysis","volume":"128","author":"Pawlowski","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.02.033","article-title":"An activated-platelet-sensitive nanocarrier enables targeted delivery of tissue plasminogen activator for effective thrombolytic therapy","volume":"300","author":"Huang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0050","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1111\/jth.13395","article-title":"Dynamics of calcium spiking, mitochondrial collapse and phosphatidylserine exposure in platelet subpopulations during activation","volume":"14","author":"Obydennyy","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2020.08.030_bb0055","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1021\/acs.biomac.6b01756","article-title":"Annexin V-conjugated mixed micelles as a potential drug delivery system for targeted thrombolysis","volume":"18","author":"Pan","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0060","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2018.12.003","article-title":"Liposomes with cyclic RGD peptide motif triggers acute immune response in mice","volume":"293","author":"Xiaoyi","year":"2019","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.jconrel.2020.08.030_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nnano.2012.237","article-title":"Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface","volume":"8","author":"Salvati","year":"2013","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2020.08.030_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2015.07.019","article-title":"Cell membrane-camouflaged nanoparticles for drug delivery","volume":"220","author":"Luk","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0075","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1073\/pnas.1106634108","article-title":"Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform","volume":"108","author":"Hu","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2020.08.030_bb0080","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1172\/JCI26987","article-title":"Thrombus formation in vivo","volume":"115","author":"Furie","year":"2005","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.jconrel.2020.08.030_bb0085","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1021\/acsnano.9b01798","article-title":"Sequentially site-specific delivery of thrombolytics and neuroprotectant for enhanced treatment of ischemic stroke","volume":"13","author":"Jianpei","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.biomaterials.2016.10.003","article-title":"Nanoparticles camouflaged in platelet membrane coating as an antibody decoy for the treatment of immune thrombocytopenia","volume":"111","author":"Wei","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0095","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz9014","article-title":"Platelet-derived porous nanomotor for thrombus therapy","volume":"6","author":"Wan","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2020.08.030_bb0100","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.2147\/DDDT.S66007","article-title":"Bioactive protein fraction DLBS1033 containing lumbrokinase isolated from lumbricus rubellus: ex vivo, in vivo, and pharmaceutic studies","volume":"8","author":"Tjandrawinata","year":"2014","journal-title":"Drug Des. Dev. Ther."},{"issue":"7571","key":"10.1016\/j.jconrel.2020.08.030_bb0105","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nature15373","article-title":"Nanoparticle biointerfacing by platelet membrane cloaking","volume":"526","author":"Hu","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201606209","article-title":"Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization","volume":"29","author":"Dehaini","year":"2017","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.jconrel.2020.08.030_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/acsnano.7b07720","article-title":"Nanoparticle functionalization with platelet membrane enables multifactored biological targeting and detection of atherosclerosis","volume":"12","author":"Xiaoli","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0120","article-title":"Ferric chloride-induced murine thrombosis models","volume":"2016","author":"Li","year":"2016","journal-title":"J. Visualiz. Exp. Jove"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0125","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1111\/j.1538-7836.2006.02093.x","article-title":"Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice","volume":"4","author":"Wang","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2020.08.030_bb0130","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1055\/s-0038-1656010","article-title":"Assessment of bleeding for the evaluation of therapeutic preparations in small animal models of antibody-induced hemophilia and von Willebrand disease","volume":"77","author":"Turecek","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2020.08.030_bb0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1160\/TH13-12-0997","article-title":"Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: analysis of repeatability and agreement of Clauss method within and between six different laboratories","volume":"112","author":"Solomon","year":"2014","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2020.08.030_bb0140","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2004.07.020","article-title":"Application of \u201cATTEMPTS\u201d for drug delivery","volume":"101","author":"Naik","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.08.030_bb0145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molmed.2004.02.008","article-title":"Role of platelet P-selectin and microparticle PSGL-1 in thrombus formation","volume":"10","author":"Furie","year":"2004","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2020.08.030_bb0150","article-title":"Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis","volume":"102","author":"Jennings","year":"2009","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2020.08.030_bb0155","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.ATV.21.1.142","article-title":"Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis","volume":"21","author":"Collet","year":"2001","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920304715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920304715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:12:20Z","timestamp":1718406740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920304715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":31,"alternative-id":["S0168365920304715"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.030","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet membrane-functionalized nanoparticles with improved targeting ability and lower hemorrhagic risk for thrombolysis therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}